Which statement by a client indicates a need for further teaching about sulfasalazine prescribed for ulcerative colitis?

The statement indicating a need for further teaching about sulfasalazine prescribed for ulcerative colitis is the one regarding constipation. Sulfasalazine is primarily used to reduce inflammation in the intestines and is known to potentially cause gastrointestinal side effects, but it is more commonly associated with diarrhea rather than constipation.

In fact, sulfasalazine can lead to side effects that include nausea, vomiting, and diarrhea due to its action on the intestines. Clients might need to be informed that while they should be aware of potential side effects, constipation is not typically one of them and that monitoring for changes in bowel habits is essential.

Understanding the pharmacological effects and side effects of sulfasalazine is crucial for proper patient education and management of ulcerative colitis. The other statements about taking the medication with meals, increased sensitivity to sunlight, and following the prescribed dosage are correct and reflect important patient considerations regarding the use of this medication.